2020台灣生技月 Bio Taiwan 生物科技大展

2020 台灣生技月 南港展覽館

講師

VenoVision

Company Presentations

Thursday, July 23 Company Presentations 4–Israel

VenoVision

Company Info

Name /VenoVision

Address /Grass Center for Bioengineering, The Hebrew University of Jerusalem, Edmond J. Safra Campus, Givat Ram, Jerusalem, Israel 9190401

Website /venovision.com

Presenter

Name /Jonathan Maron

Title /Co-Founder

Email /maron.jonathan@gmail.com

Telephone /

Fax /

Mobile /+972-54-940-9022

Company Type

Device,Diagnostics

About the Company

VenoVision takes the power of ICU-grade biometrics to the whole new level of an Ethical AI-enabled Contactless Remote Patient Monitoring Platform. It detects early abnormalities in cardiorenal and cardiopulmonary patients at risk of fluid imbalance, perioperative deterioration, or shock, and alerts medical staff before a patient’s condition spirals downward.

 

VenoVision started as a project in the BioDesign Program of the Hebrew University and has since run an industry funded human trial at Shaare Zedek Medical Center. It is currently part of the IP2 LaunchPad Taiwan-Israel Program.

 

VenoVision is looking to meet potential clinical champions, strategic partners for development and investors.

Brief Description of main products or services

Today, undetected patient deterioration is leading to ever-rising costs and harming patients’ lives, their families, and the overall quality of healthcare.

VenoVision is the next generation of monitoring - it directly competes with traditional highly-invasive products, providing decision-modifying data to improve patient outcome and guide them on their journey back from the hospital to their home and be part of a healthier community.

Product: Non-invasive remote patient monitoring, AI-enabled automated alert system, supportive diagnostic tool, home monitoring, and guided therapy.

Populations: Cardiorenal and cardiopulmonary patients.

Segments: Hospitals (perioperative care, out-patient), EMS/ED, skilled nursing facilities, long-term care facilities, home monitoring, telemedicine providers (including virtual ICU and hospital at home), and military (Tactical Combat Casualty Care, M.A.R.C.H).

Detects: fluid imbalance, perioperative deterioration, risk of shock.

Measures: Right heart function; jugular venous pressure, jugular venous waveform, skin color, peripheral temperature, heart rate, respiratory rate; expected to expand parameter portfolio.

Underlying Technology: Deep thermal imaging, computer vision analysis, proprietary algorithmic automation (ethical-AI).

Interoperability: HL7 Loinc FHIR protocol. 

Advantages: Non-contact; easy to use; provides measures recognized in medical guidelines; fills-in the data gap of current non-invasive monitoring solutions; fully integrated into the patient continuum of care.

Contact Person

Name /Jonathan

Email /maron.jonathan@gmail.com

Phone /+972-54-940-9022